CEO Sees Inequities in Patent Rights

February, 2003

SIDNEY TAUREL, CEO of pharmaceutical giant Eli Lilly, argues that legislation that chips away at patent protections is actually an attempt to limit health care spending by transferring intellectual property from innovators to imitators.

The law permits other industries to protect their trade secrets longer than the pharmaceutical industry, he said during a fall quarter View from the Top speech. “One hundred years from now, the formula for Coca-Cola could still be secret, but for the pharmaceutical industry, we can only keep competitors from acquiring and using our most valuable trade secrets—our clinical trial data—for five years.”

Previous Spreadsheet || Next Spreadsheet

Students Thrown into Leadership Roles
Fond and Not-So-Fond Memories
Shoppers Browse Mail, Mall, Web
Alumna Puts Old Bones to New Use
Poet Dana Gioia Goes to Washington
Rankings Report Card
Outsider Turns Around Nissan
Rescuing an Elephant
Research Reports: Analysis or Publicity
Solomon at Forefront of Finance Evolution
The Waiting Game
CEO Sees Inequities in Patent Rights
Battle of the Bands
Entrepreneurship at the Dining Table
For the Record: Placement Report: Class of 2002